These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 26176230)
21. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318 [TBL] [Abstract][Full Text] [Related]
22. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877 [TBL] [Abstract][Full Text] [Related]
23. Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells. Ng VY; Ang SN; Chan JX; Choo AB Stem Cells; 2010 Jan; 28(1):29-35. PubMed ID: 19785009 [TBL] [Abstract][Full Text] [Related]
24. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation. Hiraga T; Ito S; Nakamura H Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938 [TBL] [Abstract][Full Text] [Related]
25. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma. Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266 [TBL] [Abstract][Full Text] [Related]
26. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. Martowicz A; Spizzo G; Gastl G; Untergasser G BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550 [TBL] [Abstract][Full Text] [Related]
27. Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma. Sun X; Martin RCG; Zheng Q; Farmer R; Pandit H; Li X; Jacob K; Suo J; Li Y Cell Oncol (Dordr); 2018 Dec; 41(6):651-662. PubMed ID: 30116994 [TBL] [Abstract][Full Text] [Related]
28. The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer. Shigdar S; Qian C; Lv L; Pu C; Li Y; Li L; Marappan M; Lin J; Wang L; Duan W PLoS One; 2013; 8(2):e57613. PubMed ID: 23460885 [TBL] [Abstract][Full Text] [Related]
30. Single molecular recognition force spectroscopy study of a DNA aptamer with the target epithelial cell adhesion molecule. Wang N; Liu H; Hao J; Bai X; Li H; Zhang Z; Wang H; Tang J Analyst; 2015 Sep; 140(18):6226-9. PubMed ID: 26229987 [TBL] [Abstract][Full Text] [Related]
31. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809 [TBL] [Abstract][Full Text] [Related]
32. Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation. van der Gun BTF; Wasserkort R; Monami A; Jeltsch A; Raskó T; Ślaska-Kiss K; Cortese R; Rots MG; de Leij LFMH; Ruiters MHJ; Kiss A; Weinhold E; McLaughlin PMJ Int J Cancer; 2008 Jul; 123(2):484-489. PubMed ID: 18398839 [TBL] [Abstract][Full Text] [Related]
33. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer. Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650 [TBL] [Abstract][Full Text] [Related]
34. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. Terris B; Cavard C; Perret C J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402 [TBL] [Abstract][Full Text] [Related]
35. EpCAM expression in the prostate cancer makes the difference in the response to growth factors. Yoshida GJ; Saya H Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103 [TBL] [Abstract][Full Text] [Related]
36. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines. Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162 [TBL] [Abstract][Full Text] [Related]
37. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells. Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842 [TBL] [Abstract][Full Text] [Related]
38. Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX. Kim JW; Kim EY; Kim SY; Byun SK; Lee D; Oh KJ; Kim WK; Han BS; Chi SW; Lee SC; Bae KH Mol Cells; 2014 Oct; 37(10):742-6. PubMed ID: 25266702 [TBL] [Abstract][Full Text] [Related]
39. Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM. Deng Z; Wu Y; Ma W; Zhang S; Zhang YQ BMC Immunol; 2015 Jan; 16(1):1. PubMed ID: 25636521 [TBL] [Abstract][Full Text] [Related]
40. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin. Jachin S; Bae JS; Sung JJ; Park HS; Jang KY; Chung MJ; Kim DG; Moon WS Int J Oncol; 2014 Aug; 45(2):691-8. PubMed ID: 24888903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]